{
  "id": "ngn_matrixMatch_siadh_001",
  "seed": "BATCH-300-135-1771349224290",
  "itemType": "matrixMatch",
  "cjmm": "evaluateOutcomes",
  "difficulty": 4,
  "stem": "The nurse is caring for a 68-year-old male client diagnosed with small cell lung cancer who is being treated for Syndrome of Inappropriate Antidiuretic Hormone (SIADH). The client was admitted at 0800 with a serum sodium of 118 mEq/L and confusion. The current treatment plan includes a 1000 mL/day fluid restriction, seizure precautions, and a continuous infusion of 3% sodium chloride via a peripheral IV. The nurse is evaluating the client's response to treatment at 1400 over the past 24 hours.",
  "matrixMatchPrompt": "For each clinical finding, click to specify if the finding indicates the client's condition is **Improving**, **Unchanged**, or **Worsening**.",
  "rows": [
    {
      "id": "row_01",
      "rowItem": "Serum sodium level of 124 mEq/L"
    },
    {
      "id": "row_02",
      "rowItem": "Client is alert and oriented to person, place, and time"
    },
    {
      "id": "row_03",
      "rowItem": "Weight decrease of 1.5 kg since admission"
    },
    {
      "id": "row_04",
      "rowItem": "Client reports intense thirst"
    },
    {
      "id": "row_05",
      "rowItem": "Erythema and swelling noted at the peripheral IV site"
    },
    {
      "id": "row_06",
      "rowItem": "24-hour urine output of 1400 mL"
    }
  ],
  "columns": [
    {
      "id": "col_01",
      "columnItem": "Improving"
    },
    {
      "id": "col_02",
      "columnItem": "Unchanged"
    },
    {
      "id": "col_03",
      "columnItem": "Worsening"
    }
  ],
  "answer": [
    {
      "rowIndex": 0,
      "colIndex": 0
    },
    {
      "rowIndex": 1,
      "colIndex": 0
    },
    {
      "rowIndex": 2,
      "colIndex": 0
    },
    {
      "rowIndex": 3,
      "colIndex": 1
    },
    {
      "rowIndex": 4,
      "colIndex": 2
    },
    {
      "rowIndex": 5,
      "colIndex": 0
    }
  ],
  "answerBreakdown": {
    "rows": [
      {
        "id": "row_01",
        "rationale": "This finding indicates the client's condition is **Improving**. In SIADH, excessive antidiuretic hormone (ADH) leads to water retention, dilutional hyponatremia, and decreased serum osmolality. The primary goal is to correct the hyponatremia. An increase in serum sodium from a critically low 118 mEq/L to 124 mEq/L demonstrates a positive therapeutic response to fluid restriction and hypertonic saline infusion. This increase reflects a reduction in excess fluid and a restoration of electrolyte balance, mitigating the risk of neurological complications associated with severe hyponatremia.",
        "clinicalPearl": "Monitor serum sodium levels closely (every 2-4 hours) during hypertonic saline infusion to avoid rapid correction of hyponatremia, which can lead to osmotic demyelination syndrome (formerly known as central pontine myelinolysis)."
      },
      {
        "id": "row_02",
        "rationale": "This finding indicates the client's condition is **Improving**. Severe hyponatremia in SIADH causes cerebral edema due to the osmotic shift of water into brain cells. This edema manifests as neurological symptoms, including confusion, lethargy, and seizures. The client's return to being alert and oriented indicates that the serum sodium levels are rising, reducing cerebral edema and improving neuronal function. This improvement signifies that the treatment is effectively addressing the underlying pathophysiology of hyponatremic encephalopathy.",
        "clinicalPearl": "Assess neurological status frequently (every 1-2 hours initially) in clients with SIADH, including level of consciousness, orientation, pupillary response, and presence of seizures. Document findings meticulously to track progress and detect any deterioration promptly."
      },
      {
        "id": "row_03",
        "rationale": "This finding indicates the client's condition is **Improving**. SIADH leads to fluid volume excess and dilutional hyponatremia. The kidneys retain water due to the effects of ADH, leading to weight gain and increased extracellular fluid volume. A weight decrease of 1.5 kg corresponds to a fluid loss of approximately 1.5 liters. This demonstrates that the fluid restriction is effective in promoting the excretion of excess water, which is a desired outcome. This fluid loss reduces the risk of complications such as pulmonary edema and heart failure.",
        "clinicalPearl": "Daily weights (at the same time each day, using the same scale) are crucial for monitoring fluid balance in clients with SIADH. Report any significant weight gain or loss (greater than 0.5-1 kg in 24 hours) to the healthcare provider immediately."
      },
      {
        "id": "row_04",
        "rationale": "This finding indicates the client's condition is **Unchanged**. Intense thirst is an expected, albeit distressing, side effect of therapeutic fluid restriction and rising serum osmolality. As the serum sodium level increases and the body attempts to maintain homeostasis, the client experiences thirst due to the increased concentration of solutes in the bloodstream. It does not signify that the underlying SIADH is worsening; rather, it is a consequence of the treatment. The condition is not worsening, but this symptom is a persistent, anticipated challenge.",
        "clinicalPearl": "Provide comfort measures to alleviate thirst, such as frequent oral hygiene (sugar-free gum or hard candies), ice chips (if allowed within the fluid restriction), and cool cloths to the face and neck, while adhering strictly to the prescribed fluid restriction. Educate the client about the reason for the thirst and the importance of adhering to the fluid restriction."
      },
      {
        "id": "row_05",
        "rationale": "This finding indicates the client's condition is **Worsening**. Erythema and swelling at the IV site suggest a complication such as phlebitis or infiltration. Hypertonic saline (3% NaCl) is a vesicant and can cause significant tissue damage if it infiltrates into the surrounding tissues. This can lead to pain, blistering, tissue necrosis, and potential infection. This represents a new, adverse event that requires immediate nursing intervention, thus representing a worsening of the client's overall clinical situation.",
        "clinicalPearl": "Hypertonic saline should ideally be administered via a central venous catheter to minimize the risk of phlebitis and infiltration. If administered peripherally, use a large vein in the forearm or upper arm, and monitor the IV site closely (every 15-30 minutes) for signs of complications. Stop the infusion immediately if any signs of infiltration or phlebitis are present."
      },
      {
        "id": "row_06",
        "rationale": "This finding indicates the client's condition is **Improving**. The client's fluid intake is restricted to 1000 mL/day. A urine output of 1400 mL indicates a negative fluid balance of 400 mL, meaning the client is excreting more fluid than they are taking in. This is a sign that the body is effectively eliminating excess free water, a key goal in SIADH management. Increased urine output helps to correct the dilutional hyponatremia and reduce the risk of fluid overload.",
        "clinicalPearl": "Accurate intake and output monitoring is essential for assessing fluid balance in clients with SIADH. Report any significant discrepancies between intake and output (greater than 200-300 mL in 8 hours) to the healthcare provider. Monitor urine specific gravity as well; a decreasing specific gravity indicates improved fluid excretion."
      }
    ]
  },
  "references": [
    {
      "source": "Lewis's Medical-Surgical Nursing: Assessment and Management of Clinical Problems, 12th Edition",
      "chapter": "Chapter 47: Endocrine Problems"
    },
    {
      "source": "Ignatavicius, D. D., Workman, M. L., Rebar, C. R., & Heimgartner, N. M. (2021). Medical-Surgical Nursing: Concepts for Interprofessional Collaborative Care (10th ed.).",
      "chapter": "Chapter 61: Care of Patients with Pituitary and Adrenal Gland Problems"
    }
  ],
  "cognitiveProcess": "evaluateOutcomes",
  "clientNeed": "Physiological Adaptation",
  "contentArea": "Endocrine",
  "safeEffectiveCareEnvironment": [
    "Safety and Infection Control",
    "Management of Care"
  ],
  "healthPromotionAndMaintenance": [],
  "psychosocialIntegrity": [],
  "physiologicalIntegrity": [
    "Basic Care and Comfort",
    "Pharmacological and Parenteral Therapies",
    "Reduction of Risk Potential",
    "Physiological Adaptation"
  ],
  "scenarioDateTime": "14:00",
  "sbar": {
    "situation": "68-year-old male with small cell lung cancer being treated for SIADH, admitted at 0800 with serum sodium of 118 mEq/L and confusion.",
    "background": "Treatment plan includes 1000 mL/day fluid restriction, seizure precautions, and continuous infusion of 3% sodium chloride via peripheral IV.",
    "assessment": "Evaluating client's response to treatment at 1400 over the past 24 hours. Current serum sodium is 124 mEq/L. Client is alert and oriented. Weight decreased by 1.5 kg. Urine output is 1400 mL. Client reports intense thirst. Erythema and swelling noted at the peripheral IV site.",
    "recommendation": "Continue to monitor serum sodium levels, neurological status, fluid balance, and IV site closely. The peripheral IV site needs to be addressed immediately. Consider central line placement for hypertonic saline administration. Report any signs of worsening condition or complications to the provider at 1415."
  },
  "militaryTime": true,
  "sentinelStatus": "healed_v2026_v8"
}